An Asymmetric Strecker Strategy
FULL PAPER
drogen peroxide (33% w/w and 2, 6, 10, 20 or 40 equiv. with respect
to 10b-R) was then added to the medium (time t = 0). The reaction
kinetics was monitored by HPLC analysis of 0.1-mL aliquots di-
luted in HPLC eluent (1 mL): MeOH/KH2PO4 buffer (0.05 , pH
6) 55:45.
H, α-H), 7.4 (br., 5 H, C6H5), 7.5–8.0 (s, 2 H, CONH2) ppm (iden-
tical to literature data).
Decomposition of Iminodinitriles 10 (10b-R, 10b-S, 10d-R) with
AgNO3/HNO3 (Entries 14–16 in Table 1)
A solution of iminodinitrile 10 (1 mmol) in methanol was added to
aqueous AgNO3 (2 mmol, 20 mL, 0.1 ) adjusted to pH 1 by ad-
dition of HNO3 (63% w/w). This solution was heated at 50 °C for
8 h (completion monitored by TLC, eluent chloroform/acetone
97:3). Insoluble silver cyanide salts were filtered off, and then meth-
anol was removed in vacuo. The resulting aqueous solution was
washed with diethyl ether (2ϫ20 mL) to recover the chiral ketone
8. The aqueous layer was then neutralised to pH 7 by addition of
NaOH (4 ) and extracted with dichloromethane (4ϫ10 mL). The
combined organic layers were dried with Na2SO4, and the solvent
was removed in vacuo to obtain the α-aminonitrile 7. The ee was
measured as described above by GC analysis of (–)-menthyloxycar-
bonyl derivatives after hydrolysis of 7 with HCl (6 ) at 110 °C.
Optimised Conditions: Iminodinitrile 10 in methanol (0.8 mmol,
16 mL, 0.05 molL–1), reaction temperature 10 °C, pH 12.5 (pH-
stat controlled by addition of aqueous NH3 32% w/w), aqueous
hydrogen peroxide (1.5 mL, 33% w/w, 40 equiv.). After completion
of the reaction (consumption of compound 10 monitored by TLC,
eluent CHCl3/acetone, 97:3), the solvent was removed in vacuo to
afford 12 as white crystals in 90% yield.
Compound 12b-R: M.p. = 179 °C. IR (CHCCl3): 3305–3380 (NH),
3080 (CH2=CH), 2240 (CN), 1680 (C=O), 1645 (C=C) cm–1. 1H
NMR (250 MHz, CDCl3, 25 °C): δ = 1.04 (dd, 3JHH = 6.9 Hz, 4JHH
3
= 2.7 Hz, 6 H, iPr), 1.35 (t, JHH = 12.9 Hz, 1 H, 6-Hax), 1.48 [d,
3JHH = 6.8 Hz, 3 H, (CH3)a], 1.55 (m, 1 H, 4-Hax), 1.74 (s, 3 H,
CH3), 1.82 (m, 1 H, 2-Hax), 2.13 (m, 1 H, β-H), 2.22 (m, 1 H, 6-
2-Amino-3-methylbutanenitrile (D/L-Valinonitrile) (7b-R and 7b-S):
3
3
1H NMR (250 MHz, CDCl3, 25 °C): δ = 1.04 (d, JHH = 6.7 Hz, 6
Heq), 2.54 (m, 1 H, 5-Hax), 3.12 (m, 1 H, 3-Heq), 3.24 (t, JHH
=
2
3
4.6 Hz, 1 H, α-H), 4.77 (d, JHH = 24 Hz, 2 H, CH2), 6.1 (s, 1 H,
CONH-H), 6.35 (s, 1 H, CONH-H) ppm. [α]D = +12.4 (c 0.5,
MeOH). C17H26N4O (302): calcd. C 67.55, H 8.61, N 18.54; found
C 67.45, H 8.80, N 18.23.
H, iPr), 1.56 (s, 2 H, NH2), 1.90 (m, 1 H, β-H), 3.49 (d, JHH
=
1
5.7 Hz, 1 H, α-H) ppm. H NMR (250 MHz, CD3OD, 25 °C): δ =
1.15 [d, JHH = 8 Hz, 6 H, (γ-Me)2], 2.28 (m, 1 H, β-H), 4.45 (d,
3
3JHH = 5.7 Hz, 1 H, α-H) ppm.
1
2-Amino-3-phenylpropanenitrile (
D
-Phenylalaninonitrile) (7d-R): H
Compound 12c-R: M.p. = 144 °C. IR (CHCCl3): 3305–3380 (NH),
3080 (CH2=CH), 2240 (CN), 1680 (C=O), 1645 (C=C) cm–1. 1H
NMR (250 MHz, CDCl3, 25 °C): δ = 1.0 (dd, 3JHH = 6.8 Hz, 4JHH
3
NMR (250 MHz, CDCl3): δ = 1.60 (s, 2 H, NH2), 3.00 (d, JHH
13.8 Hz, 2 H, CH2), 3.90 (t, JHH = 7.1 Hz, 1 H, α-H), 7.30 (m, 5
H, C6H5) ppm. H NMR 250 MHz (CD3OD): δ = 3.20 (d, JHH
13.8 Hz, 2 H, CH2), 4.70 (t, JHH = 7.1 Hz 1 H, α-H), 7.40 (m, 5
=
3
1
3
3
=
= 2.5 Hz, 6 H, iPr), 1.4 [d, JHH = 13.1 Hz, 3 H, (CH3)a], 1.7 [s, 3
3
H, (CH3)b], 2.20–2.57 (m, 9 H, Hcyclic, β-γ-H), 3.1 (m, 1 H, 3-Heq),
3.45 (m, 1 H, α-H), 4.75 [d, 2 H, (CH2)c], 5.8 (s, 1 H, CONH-H),
6.5 (s, 1 H, CONH-H) ppm. [α]D = +11.7 (c 0.5, MeOH).
H, C6H5).
Compound 12d-R: M.p. = 145 °C. IR (CHCCl3): 3305–3380 (NH),
3080 (CH2=CH), 2240 (CN), 1680 (C=O), 1645 (C=C) cm–1. 1H
NMR (250 MHz, CDCl3, 25 °C): δ = 1.07 [d, 3 H, (CH3)a], 1.31 (t,
3JHH = 12.9 Hz, 1 H, 6-Hax), 1.45 (m, 1 H, 4-Hax), 1.72 [s, 4 H,
(CH3)a, Hax], 2.17 (m, 3 H, NH, 4-Heq, 6-Heq), 2.95 (q, 1 H, CH-
H), 3.05 (m, 1 H, 3-Heq), 3.30 (m, 1 H, CH-H), 3.70 (t, 1 H, α-H),
4.75 [d, 2 H, 3JHH = 26.5 Hz (CH2)c], 6.01 (s, 1 H, CONH-H), 6.65
(s, 1 H, CONH-H), 7.30 (m, 5 H, C6H5) ppm. [α]D = –17.7 (c 0.5,
CHCl3).
Acknowledgments
We are grateful to the French Ministry of Education and Research
for a grant to one of us (M. M.).
[1] K. Harada, Nature 1963, 200, 1201.
[2] A. Strecker, Justus Liebigs Ann. Chem. 1850, 75, 27–45.
[3] a) H. Kunz, W. Sager, Angew. Chem. Int. Engl. 1987, 26, 557–
559; b) H. Kunz, W. Sager, W. Pfrengle, D. Schanzenbach, Tet-
rahedron Lett. 1988, 29, 4397–4400; c) H. Kunz, W. Sager, D.
Schanzenbach, M. Decker, Liebigs Ann. Chem. 1991, 649–654.
[4] F. A. Davis, P. S. Portonovo, R. E. Reddy, Y. Chiu, J. Org.
Chem. 1996, 61, 440–441.
Hydrolysis of Compounds 12b–d-R (Entries 11–13 in Table 1)
Compound 12 (1 mmol) was dissolved in a mixture of methanol
(25 mL) and water (25 mL). The pH was adjusted to 1 by addition
of HCl (6 ), and then the solution was heated to 50 °C for 4 h.
After completion of the reaction (monitored by TLC with chloro-
form/acetone 97:3), the solvent was removed in vacuo. The re-
sulting aqueous phase was washed with diethyl ether (3ϫ10 mL)
to recover the chiral ketonic auxiliary 8. Evaporation of the aque-
ous layer in vacuo afforded α-amino amide 11-R as the hydrochlo-
ride salt (ee measured by polarimetry).
[5] T. Shiori, S. Harusawa, Y. Hamada, Tetrahedron Lett. 1979, 20,
4663–4666.
[6] H. Acherki, C. Alvarez-Ibarra, A. De-Dios, M. Quiroga, Tetra-
hedron 2002, 58, 3217–3327.
[7] R. O. Duthaler, Tetrahedron 1994, 50, 1539–1650.
[8] H. Gröger, Chem. Rev. 2003, 103, 2795–2827.
[9] M. Béjaud, L. Mion, A. Commeyras, Tetrahedron Lett. 1975,
16, 2985–2986.
[10] R. Pascal, J. Taillades, A. Commeyras, Tetrahedron 1978, 34,
D
-Valinamide (11b-R): [α]D = –33.3 (c 0.5, MeOH). 1H NMR
2275–2280.
(60 MHz, CD3OD, 25 °C): δ = 1.1 (d, 6 H, iPr), 2.2 (m, 1 H, β-H),
3.8 (d, 1 H, α-H), 2.2 (m, 1 H, β-H), 3.8 (d, 1 H, α-H), 7.5–8.0 (s,
2 H, CONH2) ppm (identical to literature data).
[11] a) C. Bousquet, Z. Tadros, J. Tonnel, L. Mion, J. Taillades,
Bull. Soc. Chim. Fr. 1993, 130, 513–520; b) J. Taillades, M.
Marull, J. C. Rossi, unpublished results.
[12] A. Commeyras, J. Taillades, J. Brugidou, R. Sola, A. Previero,
R. Pascal, M. Laspéras, A. Rousset, U. S. patent 4.851576,
1983.
[13] V. P. Kukhar, H. R. Hudson, Aminophosphonic and Aminophos-
phinic Acids, Wiley, 2000.
[14] A. Commeyras, J. Taillades, L. Mion, R. Pascal, M. Lasperas,
A. Rousset A U. S. patent, 4.2423814, 1981.
D
-Leucinamide (11c-R): [α]D = –11.0 (c 0.5, MeOH). 1H NMR
(60 MHz, CD3OD, 25 °C): δ = 1.15 (d, 6 H, δ-H), 1.8 (m, 3 H, β-
γ-H), 4.0 (t, 1 H, α-H), 7.5–8 (s, 2 H, CONH2) ppm (identical to
literature data).
D
-Phenylalaninamide (11d-R): [α]D = –20.7 (c 0.5, MeOH). 1H
NMR (60 MHz, CD3OD, 25 °C): δ = 3.2 (m, 2 H, β-H), 4.2 (m, 1 [15] R. Sudo, S. Ichihara, Bull. Chem. Soc. Jpn. 1963, 36, 34–37.
Eur. J. Org. Chem. 2007, 662–668
© 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
667